April 2025 in “Diagnostics” Managing inflammation and using vitamins can improve PRP therapy for better hair growth.
23 citations
,
August 2022 in “JAMA Dermatology” Patients with alopecia areata feel less regret about treatment decisions when they are involved in the decision-making process.
3 citations
,
August 2023 in “Journal of the American Academy of Dermatology” Effective hair loss counseling requires understanding individual experiences, clear communication, and shared decision-making.
April 2026 in “Expert Opinion on Biological Therapy” Prurigo nodularis is hard to diagnose and treat, but new biologics offer hope for better management.
June 2025 in “Patient Preference and Adherence” Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.
19 citations
,
December 2008 in “Arthritis Care & Research” The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.
3 citations
,
September 2024 in “JAAD reviews.” Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.
November 2024 in “Skin Appendage Disorders” Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.
34 citations
,
April 2023 in “Climacteric” Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.
1647 citations
,
June 2014 in “BMJ” Evidence-based medicine needs improvement to better tailor treatments to individual patients.
11 citations
,
November 2022 in “JAMA dermatology” Some nutritional supplements may help treat hair loss with generally mild side effects.
5 citations
,
August 2020 in “Dermatologic Therapy” Most YouTube hair loss treatment videos are popular but often biased and lack reliable sources.
4 citations
,
February 2024 in “The Journal of Urology” Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.
June 2026 in “Frontiers in Medicine” 5α-reductase inhibitors for hair loss can cause mild, reversible sexual side effects in some men.
February 2026 in “Journal of Dermatology and Skin Science” Finasteride can cause serious mental health issues, so it's advised to avoid it for hair loss.
April 2025 in “The Journal of Clinical Endocrinology & Metabolism” Hirsutism affects many women and is managed with a combination of medical treatments and hair removal, tailored to individual needs.
January 2025 in “The Journal of Dermatology” Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.
January 2025 in “Dermatology and Therapy” Hormonal therapies effectively treat acne and improve quality of life.
July 2024 in “Journal of Investigative Dermatology” Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.
July 2024 in “Journal of Investigative Dermatology” Topical corticosteroids are recommended first for treating pediatric alopecia areata due to safety and ease of use.
April 2024 in “Journal of burn care & research” Surgery for burn scar alopecia often involves multiple procedures, and treatment options should be more accessible to improve self-image.
July 2023 in “IntechOpen eBooks” New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.
3 citations
,
January 2008 in “Endocrine journal” A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.
17 citations
,
July 2006 in “The International Journal of Health Planning and Management” Healthcare organizations must seriously focus on strategic decision-making to succeed in a complex market.
2 citations
,
January 2020 in “Journal of Experimental Social Psychology” Baldness and shaved heads change how traits are seen but don't really affect leader preferences.
February 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Proper training and scientific knowledge are crucial for safe and effective chemical hair procedures.
February 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Scientific knowledge is crucial for safe and effective chemical hair procedures.
September 2025 in “Value in Health”
July 2026 in “Journal of Ovarian Research” Anti-androgen therapy is effective and safe for managing PMOS, with a focus on personalized treatment.
August 2025 in “International Journal of Dermatology” Hair loss significantly influences medical decisions, affecting treatment choices and emotional well-being.